Literature DB >> 31895059

The role of the gut microbiome in opioid use.

Michelle Ren1, Shahrdad Lotfipour1,2.   

Abstract

Although the gut and brain are separate organs, they communicate with each other via trillions of intestinal bacteria that collectively make up one's gut microbiome. Findings from both humans and animals support a critical role of gut microbes in regulating brain function, mood, and behavior. Gut bacteria influence neural circuits that are notably affected in addiction-related behaviors. These include circuits involved in stress, reward, and motivation, with substance use influencing gut microbial abnormalities, suggesting significant gut-brain interactions in drug addiction. Given the overwhelming rates of opioid overdose deaths driven by abuse and addiction, it is essential to characterize mechanisms mediating the abuse potential of opioids. We discuss in this review the role of gut microbiota in factors that influence opioid addiction, including incentive salience, reward, tolerance, withdrawal, stress, and compromised executive function. We present clinical and preclinical evidence supporting a bidirectional relationship between gut microbiota and opioid-related behaviors by highlighting the effects of opioid use on gut bacteria, and the effects of gut bacteria on behavioral responses to opioids. Further, we discuss possible mechanisms of this gut-brain communication influencing opioid use. By clarifying the relationship between the gut microbiome and opioid-related behaviors, we improve understanding on mechanisms mediating reward-, motivation-, and stress-related behaviors and disorders, which may contribute to the development of effective, targeted therapeutic interventions in opioid dependence and addiction.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31895059      PMCID: PMC7908675          DOI: 10.1097/FBP.0000000000000538

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.293


  153 in total

Review 1.  Metabolic tinkering by the gut microbiome: Implications for brain development and function.

Authors:  Joel Selkrig; Peiyan Wong; Xiaodong Zhang; Sven Pettersson
Journal:  Gut Microbes       Date:  2014-03-31

2.  Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve.

Authors:  Javier A Bravo; Paul Forsythe; Marianne V Chew; Emily Escaravage; Hélène M Savignac; Timothy G Dinan; John Bienenstock; John F Cryan
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-29       Impact factor: 11.205

3.  Prevention of gut leakiness by a probiotic treatment leads to attenuated HPA response to an acute psychological stress in rats.

Authors:  Afifa Ait-Belgnaoui; Henri Durand; Christel Cartier; Gilles Chaumaz; Hélène Eutamene; Laurent Ferrier; Eric Houdeau; Jean Fioramonti; Lionel Bueno; Vassilia Theodorou
Journal:  Psychoneuroendocrinology       Date:  2012-04-26       Impact factor: 4.905

4.  Gut microbiota modulates alcohol withdrawal-induced anxiety in mice.

Authors:  Hui-Wen Xiao; Chang Ge; Guo-Xing Feng; Yuan Li; Dan Luo; Jia-Li Dong; Hang Li; Haichao Wang; Ming Cui; Sai-Jun Fan
Journal:  Toxicol Lett       Date:  2018-01-31       Impact factor: 4.372

5.  Exposure to severe wartime conditions in early life is associated with an increased risk of irritable bowel syndrome: a population-based cohort study.

Authors:  Tamira K Klooker; Breg Braak; Rebecca C Painter; Susanne R de Rooij; Ruurd M van Elburg; Rene M van den Wijngaard; Tessa J Roseboom; Guy E Boeckxstaens
Journal:  Am J Gastroenterol       Date:  2009-06-09       Impact factor: 10.864

6.  Obese-type gut microbiota induce neurobehavioral changes in the absence of obesity.

Authors:  Annadora J Bruce-Keller; J Michael Salbaum; Meng Luo; Eugene Blanchard; Christopher M Taylor; David A Welsh; Hans-Rudolf Berthoud
Journal:  Biol Psychiatry       Date:  2014-07-18       Impact factor: 13.382

7.  GLP-1 analog attenuates cocaine reward.

Authors:  D L Graham; K Erreger; A Galli; G D Stanwood
Journal:  Mol Psychiatry       Date:  2012-10-23       Impact factor: 15.992

8.  Central & peripheral glucagon-like peptide-1 receptor signaling differentially regulate addictive behaviors.

Authors:  Sunil Sirohi; Jennifer D Schurdak; Randy J Seeley; Stephen C Benoit; Jon F Davis
Journal:  Physiol Behav       Date:  2016-04-09

9.  Opioid-induced gut microbial disruption and bile dysregulation leads to gut barrier compromise and sustained systemic inflammation.

Authors:  S Banerjee; G Sindberg; F Wang; J Meng; U Sharma; L Zhang; P Dauer; C Chen; J Dalluge; T Johnson; S Roy
Journal:  Mucosal Immunol       Date:  2016-02-24       Impact factor: 7.313

Review 10.  The New Era of Treatment for Obesity and Metabolic Disorders: Evidence and Expectations for Gut Microbiome Transplantation.

Authors:  Thilini N Jayasinghe; Valentina Chiavaroli; David J Holland; Wayne S Cutfield; Justin M O'Sullivan
Journal:  Front Cell Infect Microbiol       Date:  2016-02-19       Impact factor: 5.293

View more
  11 in total

1.  Evidence for Modulation of Substance Use Disorders by the Gut Microbiome: Hidden in Plain Sight.

Authors:  Mariana Angoa-Pérez; Donald M Kuhn
Journal:  Pharmacol Rev       Date:  2021-04       Impact factor: 25.468

Review 2.  Unique Pharmacology, Brain Dysfunction, and Therapeutic Advancements for Fentanyl Misuse and Abuse.

Authors:  Ying Han; Lu Cao; Kai Yuan; Jie Shi; Wei Yan; Lin Lu
Journal:  Neurosci Bull       Date:  2022-05-15       Impact factor: 5.271

Review 3.  Role of microbes in the pathogenesis of neuropsychiatric disorders.

Authors:  Aranyak Goswami; Frank R Wendt; Gita A Pathak; Daniel S Tylee; Flavio De Angelis; Antonella De Lillo; Renato Polimanti
Journal:  Front Neuroendocrinol       Date:  2021-05-04       Impact factor: 8.333

Review 4.  Contributions of neuroimmune and gut-brain signaling to vulnerability of developing substance use disorders.

Authors:  Kelsey E Lucerne; Aya Osman; Katherine R Meckel; Drew D Kiraly
Journal:  Neuropharmacology       Date:  2021-05-06       Impact factor: 5.273

Review 5.  Drugs and Bugs: The Gut-Brain Axis and Substance Use Disorders.

Authors:  Sierra Simpson; Rio Mclellan; Emma Wellmeyer; Frederic Matalon; Olivier George
Journal:  J Neuroimmune Pharmacol       Date:  2021-10-25       Impact factor: 7.285

Review 6.  Emotionality vs. Other Biobehavioural Traits: A Look at Neurochemical Biomarkers for Their Differentiation.

Authors:  Irina N Trofimova; Anastasia A Gaykalova
Journal:  Front Psychol       Date:  2021-12-20

Review 7.  Less Well-Known Consequences of the Long-Term Use of Opioid Analgesics: A Comprehensive Literature Review.

Authors:  Aleksandra Kotlińska-Lemieszek; Zbigniew Żylicz
Journal:  Drug Des Devel Ther       Date:  2022-01-18       Impact factor: 4.162

8.  Fecal microbiota transplantation and antibiotic treatment attenuate naloxone-precipitated opioid withdrawal in morphine-dependent mice.

Authors:  Ana C Thomaz; Vishakh Iyer; Taylor J Woodward; Andrea G Hohmann
Journal:  Exp Neurol       Date:  2021-06-18       Impact factor: 5.620

9.  Prenatal opioid administration induces shared alterations to the maternal and offspring gut microbiome: A preliminary analysis.

Authors:  Gregory G Grecco; Yong Gao; Hongyu Gao; Yunlong Liu; Brady K Atwood
Journal:  Drug Alcohol Depend       Date:  2021-07-28       Impact factor: 4.852

10.  Integrated analysis of concomitant medications and oncological outcomes from PD-1/PD-L1 checkpoint inhibitors in clinical practice.

Authors:  Alessio Cortellini; Marco Tucci; Vincenzo Adamo; Luigia Stefania Stucci; Alessandro Russo; Enrica Teresa Tanda; Francesco Spagnolo; Francesca Rastelli; Renato Bisonni; Daniele Santini; Marco Russano; Cecilia Anesi; Raffaele Giusti; Marco Filetti; Paolo Marchetti; Andrea Botticelli; Alain Gelibter; Mario Alberto Occhipinti; Riccardo Marconcini; Maria Giuseppa Vitale; Linda Nicolardi; Rita Chiari; Claudia Bareggi; Olga Nigro; Alessandro Tuzi; Michele De Tursi; Nicola Petragnani; Laura Pala; Sergio Bracarda; Serena Macrini; Alessandro Inno; Federica Zoratto; Enzo Veltri; Barbara Di Cocco; Domenico Mallardo; Maria Grazia Vitale; David James Pinato; Giampiero Porzio; Corrado Ficorella; Paolo Antonio Ascierto
Journal:  J Immunother Cancer       Date:  2020-11       Impact factor: 13.751

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.